Praxis Precision Medicines (PRAX) operating margin
Only 2 fiscal years of operating margin are on record here for Praxis Precision Medicines (PRAX); a history needs at least 3. Figures as of 17 Nov 2026, 21:50 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Operating margin, fiscal 2024
- -2340.3%
- Change on fiscal 2023
- +2824.1 pts
- Fiscal years on record
- 22023–2024
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.
Not enough data
A history of operating margin needs at least 3 fiscal years; 2 are on record here for Praxis Precision Medicines. Nothing is estimated to fill the gap. What is on record is in the table below.
Praxis Precision Medicines operating margin, year by year
| Fiscal year | Operating margin | Change | Year ended | Net margin |
|---|---|---|---|---|
| 2024 | -2340.3% | 2824.1 pts up | -2137.5% | |
| 2023 | -5164.4% | — | -5037.9% |
Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.
How to read it
It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.
Operating margin at health care companies of similar size
| Company | Operating margin | Fiscal year |
|---|---|---|
| Oscar Health OSCR | -10094.2% | 2021 |
| TG Therapeutics TGTX | 20.0% | 2025 |
| Praxis Precision Medicines PRAX | -2340.3% | 2024 |
| Twist Bioscience TWST | -36.2% | 2025 |
| Protagonist Therapeutics PTGX | -343.6% | 2025 |
| Krystal Biotech KRYS | 41.5% | 2025 |
The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.
Praxis Precision Medicines, figure by figure
- Praxis Precision Medicines market cap
- Praxis Precision Medicines revenue
- Praxis Precision Medicines earnings
- Praxis Precision Medicines earnings per share (EPS)
- Praxis Precision Medicines P/E ratio
- Praxis Precision Medicines P/S ratio
- Praxis Precision Medicines P/B ratio
- Praxis Precision Medicines free cash flow
- Praxis Precision Medicines dividend
- Praxis Precision Medicines shares outstanding
- Praxis Precision Medicines total debt
- Praxis Precision Medicines cash on hand
- Praxis Precision Medicines total assets
- Praxis Precision Medicines return on equity (ROE)
- Praxis Precision Medicines return on invested capital (ROIC)
Praxis Precision Medicines (PRAX) overview: price, valuation and scorecardAll health care companies by market value
Praxis Precision Medicines operating margin: questions and answers
How is Praxis Precision Medicines's operating margin calculated?
Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.
Fiscal years are named for the calendar year they end in.
Learn: operating margin
All stocks guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Praxis Precision Medicines (PRAX) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/PRAX/operating-margin
Underlying data: the company's filings with the SEC and Yahoo Finance.